...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Exempt Distribution Jan 20

I see on SEDAR there was an exempt distribution done on Jan 20. An investor in the US paid $1.50 US per unit (1 share plus 1/2 warrant) for 166,667 units. Worked out to $318,334 CAN ($1.91 CAN/unit). Full warrants are exercisable at $1.91 CAN, expire Jan 20/22. 

Share
New Message
Please login to post a reply